France's Dassault to buy Medidata Solutions for $5.7b

France's Dassault to buy Medidata Solutions for $5.7b

A research technologist prepares a Tessa Therapeutics Pte. virus specific t-cells (VST) infusion for cancer patients as part of a clinical trial inside a good manufacturing practice (GMP) room at Singapore's National Cancer Center (NCCS) in Singapore, on Thursday, Feb 23, 2017. Photographer: Nicky Loh/Bloomberg

Dassault Systemes SE, a maker of industrial design software, agreed to buy Medidata Solutions Inc. for $5.7 billion to gain a foothold in the fast-growing market for clinical trial technology.